Today: 19 May 2026
DroneShield (ASX:DRO) share price: set for Monday test after 7.5% Friday drop and pipeline reset
1 February 2026
2 mins read

DroneShield (ASX:DRO) share price: set for Monday test after 7.5% Friday drop and pipeline reset

Sydney, Feb 1, 2026, 17:42 AEDT — The market has closed.

  • DroneShield shares ended Friday at A$3.32, slipping 7.5%.
  • Since closing on Jan. 23, the stock has dropped roughly 26% following four consecutive days of declines.
  • Investors are focused on the A$2.09 billion pipeline alongside the release timing of audited FY2025 results.

DroneShield shares slipped 7.5% to finish Friday at A$3.32, putting the counter-drone company at a disadvantage as it enters the new week.

Since closing on Jan. 23, the stock has dropped roughly 25.7%, with steep daily losses piling up into the end of the month. Moves like this usually shake out short-term investors or attract new sellers.

Why it matters now: investors are weighing DroneShield’s recent quarterly report and its impact on deal conversions in 2026. For high-growth defense tech firms, a new contract announcement can shift sentiment sharply—but a weaker pipeline figure can do just as much damage.

DroneShield’s filings are crucial since its sales often come in fits and starts — a handful of big defence contracts can change a quarter’s picture entirely. Investors zero in on the “pipeline” of potential, unsigned deals and the actual cash received before the market kicks back into gear.

The company posted A$51.3 million in revenue for the quarter ended Dec. 31, a 94% jump from the previous year, alongside customer cash receipts of A$63.5 million. Operating cash flow swung to a positive A$7.7 million, compared with an A$8.9 million outflow a year earlier. It holds A$95.6 million in committed revenue for 2026, and cash and equivalents stood at A$210.4 million at quarter-end. The update highlighted contracts worth A$49.6 million with a European military client and A$25.3 million in Latin America. Audited FY2025 results are expected in February.

DroneShield reported its sales pipeline at A$2.09 billion in January, down from A$2.5 billion in October, according to an investor presentation released alongside the update. The company attributed the decline mainly to early-stage, low-probability projects that either stalled or were scaled back, as well as a stronger Australian dollar. It also emphasized that the pipeline is unweighted and doesn’t guarantee future sales.

A separate ASX filing on Thursday revealed the company applied to list 4.565 million new fully paid ordinary shares. These came from exercised options or converted securities. Even a relatively small uptick in supply can impact a stock already under pressure.

CEO Oleg Vornik said on this week’s earnings call that the company kicked off 2026 with “essentially AUD 100 million” in locked-in revenues already secured. He added they don’t offer guidance because “it would just be irresponsible” in such a “nascent industry.” Investing.com Nigeria

But the next move isn’t set in stone. Defence and security contracts often drag on, budgets shift, and pipelines get reshuffled — particularly when early-stage projects hang in the balance and might never actually close. Following a 26% drop in a single week, the price action alone could trigger further swings.

Shares resume trading Monday, Feb. 2, as investors look for new contract updates and signs that selling pressure might be easing. Attention now shifts to the company’s audited FY2025 results, expected to be released in February.

Stock Market Today

  • India IPO Fundraising Drops to Two-Year Low in Early 2026 with Uncertain Outlook for H2
    May 19, 2026, 6:19 AM EDT. India's IPO fundraising has plunged to Rs 56,322 crore in the first five months of 2026, marking a sharp decline from Rs 82,678 crore in the same period last year and a two-year low, according to Primedatabase. Contributing factors include market volatility, geopolitical tensions, and cautious investor behavior amid global uncertainties. Notably, average subscription rates fell to roughly 2x in early 2026 from 38x in H2 2025, signaling weakened appetite. Despite a healthy pipeline with major listings from NSE and Jio Platforms expected in the second half, experts warn recovery will be cautious and selective. Institutional investors now favor profitable, scalable firms over aggressive growth models. The primary market slowdown contrasts with record 2025 fundraising and raises concerns about H2 momentum.

Latest articles

Hesai Up Premarket After Mercedes Lidar Win, Q1 Profit

Hesai Up Premarket After Mercedes Lidar Win, Q1 Profit

19 May 2026
Hesai Group shares rose 2.68% to $22.60 in U.S. premarket trading after reporting a first-quarter profit and confirming it will supply lidar sensors for Mercedes-Benz Level 3 autonomous models. The company shipped 471,723 lidar units, up 140.9% year-on-year, and posted revenue of RMB680.6 million ($98.7 million). Net income reached RMB18.3 million, reversing a loss from a year earlier.
Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

19 May 2026
Virax Biolabs shares surged 53.1% Monday to $0.2350 and climbed another 17.1% in early Tuesday premarket trading, hitting $0.2751. The rally followed a paid RedChip TV appearance and a May 15 ownership filing showing Armistice Capital with a 4.99% stake. No new clinical or product updates were posted. Trading volume Monday reached about 765.2 million shares.
Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

19 May 2026
Amesite Inc. shares surged 218% to $2.50 in premarket trading after announcing its largest NurseMagic deployment with a 2,700-patient home-care client. The company disclosed $83,332 in quarterly revenue and a $678,061 net loss, with cash at $740,711 before a $2.2 million April financing. Amesite did not reveal the new contract’s value or customer name. Its latest filing cited “substantial doubt” about ongoing operations.

Popular

Intel Shares Edge Up as AI Chip Trade Runs Into Hurdles

Intel Shares Edge Up as AI Chip Trade Runs Into Hurdles

18 May 2026
Intel shares rose 0.3% to $109.10 in early New York trading Monday after last week’s selloff, as analysts raised price targets and President Trump commented on the U.S. government’s 10% stake, now valued above $50 billion. First-quarter revenue climbed 7% to $13.6 billion, with Data Center and AI sales up 22%. The iShares Semiconductor ETF fell 0.9%. Intel’s server CPU market share dropped to 54.9% in Q1, according to UBS.
Renesas stock price: Wolfspeed stake update lands days before Feb. 5 earnings
Previous Story

Renesas stock price: Wolfspeed stake update lands days before Feb. 5 earnings

Saks Off 5th liquidation sales begin as Saks Global moves to close 57 stores
Next Story

Saks Off 5th liquidation sales begin as Saks Global moves to close 57 stores

Go toTop